USFDA issues import alert for Ranbaxy Mohali facilities

Name: USFDA issues import alert for Ranbaxy Mohali facilities
Uploaded: 2018-02-16T16:08:37+00:00
Duration: 2 min 24 s
Channel: Mint
Description: In a major blow to Ranbaxy Laboratories, USFDA has imposed a ban against its Mohali facilities. This ban is likely to impact Ranbaxy's export plans. Mint's CH Unnikrishnan has more on this

Mint

In a major blow to Ranbaxy Laboratories, USFDA has imposed a ban against its Mohali facilities. This ban is likely to impact Ranbaxy's export plans. Mint's CH Unnikrishnan has more on this

Category

Be the first to comment

Recommended